Ann Dermatol.  2017 Jun;29(3):385-387. 10.5021/ad.2017.29.3.385.

Acitretin as a Therapeutic Option for Chronic Hand Eczema

• Song M
• Lee HJ
• Lee WK
• Kim HS
• Ko HC
• Kim MB
• Kim BS

• KMID: 2378552
• DOI: http://doi.org/10.5021/ad.2017.29.3.385

Abstract

No abstract available.

MeSH Terms

Acitretin*
Eczema*
Hand*
Acitretin

Figure

• 

  Fig. 1 Change in physician global assessment during the 8-week period.

Reference

1. Paulden M, Rodgers M, Griffin S, Slack R, Duffy S, Ingram JR, et al. Alitretinoin for the treatment of severe chronic hand eczema. Health Technol Assess. 2010; 14:Suppl 1. 39–46.

2. Pearce DJ, Nelson AA, Fleischer AB, Balkrishnan R, Feldman SR. The cost-effectiveness and cost of treatment failures associated with systemic psoriasis therapies. J Dermatolog Treat. 2006; 17:29–37.

3. Coenraads PJ. Hand eczema. N Engl J Med. 2012; 367:1829–1837.

4. Niu X, Cao W, Ma H, Feng J, Li X, Zhang X. Acitretin exerted a greater influence on T-helper (Th)1 and Th17 than on Th2 cells in treatment of psoriasis vulgaris. J Dermatol. 2012; 39:916–921.

5. Sarkar R, Chugh S, Garg VK. Acitretin in dermatology. Indian J Dermatol Venereol Leprol. 2013; 79:759–771.

6. Capella GL, Fracchiolla C, Frigerio E, Altomare G. A controlled study of comparative efficacy of oral retinoids and topical betamethasone/salicylic acid for chronic hyperkeratotic palmoplantar dermatitis. J Dermatolog Treat. 2004; 15:88–93.

7. Tan J, Maari C, Nigen S, Bolduc C, Bissonnette R. Open-label exploratory study of acitretin for the treatment of severe chronic hand dermatitis. J Dermatolog Treat. 2015; 26:373–375.

8. Thestrup-Pedersen K, Andersen KE, Menné T, Veien NK. Treatment of hyperkeratotic dermatitis of the palms (eczema keratoticum) with oral acitretin. A single-blind placebo-controlled study. Acta Derm Venereol. 2001; 81:353–355.

9. Ruzicka T, Lynde CW, Jemec GB, Diepgen T, Berth-Jones J, Coenraads PJ, et al. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. Br J Dermatol. 2008; 158:808–817.